| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/07/2004 | EP1404303A1 Stable pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404301A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1317459B1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 04/07/2004 | EP1307457B1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 04/07/2004 | EP1226433B1 Method for identifying active anti-apoptosis compounds |
| 04/07/2004 | EP1214307B1 4-oxybenzopyran derivative |
| 04/07/2004 | EP1171110B1 Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis |
| 04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
| 04/07/2004 | EP1105401B1 Phosphoglycolipid and methods for its use |
| 04/07/2004 | EP1076556B1 Administration of resveratrol to prevent or treat restenosis following coronary intervention |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | CN1487952A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487923A Process for the preparation of (3-cyano-1H-indol-7-yl) (4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 04/07/2004 | CN1487919A New mandelic acid derivatives and their use as throbin inhibitors |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/07/2004 | CN1487828A New film coating |
| 04/07/2004 | CN1487085A Conotoxin MVÔàí A and Trx fusion protein and its expression and application |
| 04/07/2004 | CN1486991A Figwort polysaccharide and its production process and use |
| 04/07/2004 | CN1486745A Stem cell prepn for treating tissue ischemia disease and its prepn process |
| 04/07/2004 | CN1486744A Application of neutral proteinase in preparing medicine for anorectal diseases and the medicine |
| 04/07/2004 | CN1486739A Chinese medicine composition for treating apoplexy |
| 04/07/2004 | CN1486730A Capsule prepn for regulating blood fat and blood pressure |
| 04/07/2004 | CN1486729A Medicine for treating and preventing hypertenston and hyperlipemia and its prepn |
| 04/07/2004 | CN1486715A Ginkgo leaf powder for injection and its prepn |
| 04/07/2004 | CN1486689A Propranolol hydrochloride dripping pill and its prepn |
| 04/07/2004 | CN1486688A Application of 1-heptanol in preparing medicine for acute and chronic cerebrovascular cramp |
| 04/07/2004 | CN1144806C Thienopyrimidines compound |
| 04/07/2004 | CN1144805C Bridged bispidine compounds, its preparing method and intermediate and use for treatment of cardiac arrhythmias |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines |
| 04/07/2004 | CN1144790C Telmisartan polymorphs, producing process thereof and use in prepn. of pharmaceutical composition thereof |
| 04/07/2004 | CN1144789C Pyrrolidine and piperidine derivatives, producing process and application thereof |
| 04/07/2004 | CN1144787C Aryl fused azapolycyclic compounds |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/07/2004 | CN1144598C Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 04/06/2004 | US6717012 Such as alpha-phenyl-n-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide |
| 04/06/2004 | US6717008 Use as anorectics, treating obesity and type ii diabetes; c2-substituent is a sulfonyl-, sulfinyl- or sulfide-containing group, and indan 1-hydroxy group is esterified, etherified or a carbonate group |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716877 Method to treat chronic heart failure and/or elevated cholesterol levels |
| 04/06/2004 | US6716875 With angiotensin ii antagonist (losartan); angiotensin i converting enzyme inhibitor (captopril); hypotensive agent and for congestive heart failure; renin inhibitor is peptide |
| 04/06/2004 | US6716872 Using the compounds for treating pain, anxiety and various other diseases or conditions. |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716869 N-(2-(1-amidinopyrrol-3-yl)ethyl)-5,6-dihydroxy-1-(2-(2-methox y-3-sulfatopropionylamino)-3-chloro-4-methylvaleroyl)indole-2-carboxamide |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716860 Azo amino acids derivatives |
| 04/06/2004 | US6716856 Cell proliferative disorders or alzheimer's disease; reduced toxicity; cdk/cyclin kinase inhibitory activity |
| 04/06/2004 | US6716855 Antithrombotic amides |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716842 Non-insulin dependent diabetes mellitus, obesity, hyperglycemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia in a mammal |
| 04/06/2004 | US6716839 Inhibitor of factor xa |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like. |
| 04/06/2004 | US6716822 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716585 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis |
| 04/06/2004 | US6716413 Indole compounds as tissue-specific exogenous optical agents |
| 04/06/2004 | CA2299399C Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/06/2004 | CA2060616C Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 04/01/2004 | WO2004026890A1 Acetylene compounds |
| 04/01/2004 | WO2004026879A1 Clopidogrel |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026834A1 Crystalline organic acid salt of amlodipine |
| 04/01/2004 | WO2004026833A1 Cyclic amine compound, process for producing the same, and use |
| 04/01/2004 | WO2004026832A1 Urea compound and use thereof |
| 04/01/2004 | WO2004026816A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026361A1 Controllable drug releasing gradient coatings for medical devices |
| 04/01/2004 | WO2004026342A1 AGENT CONTAINING NFκB DECOY FOR PROTECTING GRAFT AGAINST NEOINTIMAL THICKENING |
| 04/01/2004 | WO2004026285A2 Compositions and methods for treating heart disease |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003097658A3 Compounds and methods for inhibiting selectin-mediated function |
| 04/01/2004 | WO2003097633A8 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 04/01/2004 | WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands |
| 04/01/2004 | WO2003095471A3 Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation |
| 04/01/2004 | WO2003092767A3 A method for inhibiting platelet aggregation |
| 04/01/2004 | WO2003089934A3 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1 |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003084566A3 Proteins involved in the regulation of energy homeostasis |
| 04/01/2004 | WO2003082874A3 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 04/01/2004 | WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 04/01/2004 | WO2003079998A3 Treatment of diseases involving defective gap junctional communication |
| 04/01/2004 | WO2003077865A3 Methods and compositions for directing cells to target organs |
| 04/01/2004 | WO2003077864A3 Methods and compositions for directing cells to target organs |
| 04/01/2004 | WO2003076408A3 Indazole derivatives that are activators of soluble guanylate cyclase |
| 04/01/2004 | WO2003075834A3 Activated protein c formulations |
| 04/01/2004 | WO2003074078A3 Cg3842 homologous proteins involved in the regulation of energy homeostasis |